Cargando…
Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
The past ten years parallels have been drawn between the biology of cancer and pulmonary fibrosis. The unremitting recruitment and maintenance of the altered fibroblast phenotype with generation and proliferation of immortal myofibroblasts is reminiscent with the transformation of cancer cells. A ha...
Autores principales: | Tzouvelekis, Argyris, Anevlavis, Stavros, Bouros, Demosthenes |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524948/ https://www.ncbi.nlm.nih.gov/pubmed/16725031 http://dx.doi.org/10.1186/1465-9921-7-82 |
Ejemplares similares
-
Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005) -
Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020) -
Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012) -
Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
por: Panagou, Panagiotis, et al.
Publicado: (2004) -
Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019)